Comparative analysis of the efficiency of plasma transusretral methods of treatment of benign prostatic hyperplasia
DOI:
https://doi.org/10.25726/NM.2019.49.40.004Keywords:
benign prostatic hyperplasia, plasmokinetic transurethral resection, plasmokinetic transurethral enucleation, open prostatectomy, blood loss, surgical treatmentAbstract
The article presents a comparative study of the results of plasma endoscopic technologies and open prostatectomy in the treatment of benign prostatic hyperplasia (BPH) of medium and large sizes.
Foundation on which the study was conducted, was the Center of endourology at REGIONAL clinical hospital №7, Kazan. Evaluation of perioperative results of endoscopic treatment of BPH was carried out on the basis of current observation for the period 2015-2018.
With equal surgical efficiency of the methods, the team of authors found that the use of endourethral techniques gives a significant reduction in the number of intra- and postoperative complications. Reduction of hemorrhagic, infectious and inflammatory complications during surgery and in the early postoperative period leads to a reduction in the duration of bladder drainage and the average duration of hospitalization. The use of modern equipment operating on the platform "PLASMA", in comparison with the previously used equipment for bipolar operations can reduce the time of surgical intervention in the performance of endoscopic enucleation.
The revealed advantages of transurethral methods of treatment of BPH indicate a higher profile of their safety and efficiency, which gives grounds for the inclusion of plasma kinetic endourethral methods of operations in the standard urological treatment of patients of this profile.
References
1. Apolikhin O.I., Sivkov A.V., Beshliev D.A., Solntseva T.V., Komarova V.A., Zaitsevskaya E.V. Analysis of urological morbidity in the Russian Federation in 2002-2009 according to official statistics. Experimental and clinical urology. 2011. No1. S. 4-10.
2. Danilov VV, Osinkin KS, Danilov VV, Sevryukov F.A. Alpha1-blockers and detrusor hyperactivity in patients with prostate adenoma. Questions of urology and andrology. 2018.Vol. 6. No. 2. P. 49-53.
3. Ilchenko G.V., Ischenko O.Yu., Lynova E.N., Prishchep L.V. Assessment of organizational loyalty in medical institutions. International Journal of Medicine and Psychology. 2018. Volume 1. No. 4. S. 24-35.
4. Kamyshov S.V., Pulatov D.A., Yuldasheva N.Sh., Balenkov O.Yu. Study of the influence of immunotherapy methods on peroxidation processes in the accompanying treatment of cervical cancer. Eurasian Oncology Journal. 2015. No. 4 (7). S. 60-66.
5. Kulikova N.G., Kamurzoeva S.Sh. Medical and social characteristics of patients of working age with primary disability. Problems of social hygiene, health care and the history of medicine. 2014.Vol. 22. No. 2. P. 14-16.
6. Pulatov D.A., Ibragimov Zh.M., Kamyshov S.V. Comparative evaluation of the toxicity of treatment of patients with chemoresistant colorectal cancer. Oncology and radiology of Kazakhstan. 2017. No. 2 (44). S. 58-61.
7. Salalykina E.V., Papikyan O.A. Issues of optimizing the work of paramedical personnel in a central district hospital. International Journal of Medicine and Psychology. 2018. Volume 1. No. 2. S. 12-16.
8. Sevryukov F.A. The quality of life of patients after transurethral enucleation of large prostate adenomas. Andrology and genital surgery. 2012. T. 13. No. 3. P. 42-46.
9. Sevryukov F.A. Transurethral resection in saline. Urology. 2012. No. 2. P. 67-70.
10. Sevryukov F.A., Kamaev I.A., Malinina O.Yu., Mushroom M.N., Perevezentsev E.A. The social status of patients suffering from benign prostatic hyperplasia. Public health and healthcare. 2011. No 1. S. 53-56.
11. Sevryukov F.A., Malinina O.Yu. New organizational technologies for providing medical care to patients with benign prostatic hyperplasia. Social aspects of public health. 2012. V. 23. No. 1. S. 1-7.
12. Sevryukov F.A., Puchkin A.B., Krupin V.N., Chebykin A.V., Sorokin D.A., Karpukhin I.V., Malinina O.Yu., Zorin D.G. New Generation Transurethral Electrosurgery (TURIS) in the treatment of diseases of the lower urinary tract and prostate. Urology. 2007. No. 3. P. 28-35.
13. Sevryukov F.A., Serebryany S.A. A case of successful transurethral enucleation of prostate adenoma is very large. Andrology and genital surgery. 2012.V. 13. No. 3. S. 101-103.
14. Semenychev D.V., Sevryukov F.A., Sorokin D.A., Karpukhin I.V., Puchkin A.B., Kochkin A.D. Experience with the use of bipolar vapor resection of the prostate gland (TUVRB) in the treatment of BPH. Experimental and clinical urology. 2014. No. 2. P. 49-53.
15. Semenychev D.V., Sevryukov F.A., Sorokin D.A., Karpukhin I.V., Puchkin A.B., Kochkin A.D., Knutov A.V. Comparative evaluation of the effectiveness of various energy blocks in bipolar prostate surgery. Pacific Medical Journal. 2017. No. 1 (67). S. 88-90.
16. Sorokin D.A., Sevryukov F.A., Semenychev D.V., Karpukhin I.V., Puchkin A.B., Kochkin A.D., Knutov A.V. The results of the use of hyaluronic acid after transurethral endoscopic surgery for benign prostatic hyperplasia. Medical Bulletin of Bashkortostan. 2015.V. 10. No. 3. P. 19-24.
17. Urology. Russian Clinical Recommendations, ed. Yu. G. Alyaev, P.V. Glybochko, D. Yu. Pushkar. M.: GEOTAR-Media, 2016.496 s.
18. Khamurzoeva S.Sh., Kulikova N.G. Ways to reduce disability in people of working age. Problems of social hygiene, health care and the history of medicine. 2013. No. 6. S. 29-31.
19. Bachmann A, Tubaro A, Barber N, d’Ancona F, Muir G, Witzsch U et al. 180-W XPS GreenLight laser vaporisation versus transurethral resection of the prostate for the treatment of benign prostatic obstruction: 6-month safety and efficacy results of a European Multicentre Randomised Trial–the Goliath study Eur Urol. 2014. 65(5):931-942
20. da Silva R.D., Bidikov L., Michaels W. et al. Bipolar energy in the treatment of benign prostatic hyperplasia: a current systematic review of the literature. Can J Urol 2015;22 Suppl 1:30-44.
21. EAU guidelines on the treatment and follow-up of nonneurogenic male lower urinary tract symptoms including benign prostatic obstruction M. Oelke [et al.]. European Urology. 2013. Vol. 64, № 1. P. 118-140.
22. Geavlete B, Stanescu F, Iacoboaie C, Geavlete P. Bipolar plasma enucleation of the prostate vs open prostatectomy in large benign prostatic hyperplasia cases - A medium term, prospective, randomized comparison. BJU Int. 2013 May;111(5):793-803.
23. Lee Y.T., Ryu Y.W., Lee D.M. at al. Comparative Analysis of the Efficacy and Safety of Conventional Transurethral Resection of the Prostate, Transurethral Resection of the Prostate in Saline (TURIS), and TURIS-Plasma Vaporization for the Treatment of BPH: A Pilot Study. Korean J Urol. 2011. Nov; 52(11). Р. 763-8.
24. Nakagava, K. A new minimally invasive medical treatment for prostatic hyperplasia: its current situation and actual practice of the operation; TUEB. K. Nakagava. Urology View. 2007. Vol. 5. P. 95-97.
25. Reich O, Gratzke C, Bachmann A, Seitz M, Schlenker B, Hermanek P et al. Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10,654 patients. J Urol. 2008. 180(1):246-249.
26. Serretta V, Morgia G, Fondacaro L, Curto G, Lo bianco A, Pirritano D et al Open prostatectomy for benign prostatic enlargement in southern Europe in the late 1990s: a contemporary series of 1800 interventions. Urology. 2002. 60(4):623-627
27. Thangasamy IA, Chalasani V, Bachmann A, Woo HH. Photoselective vaporisation of the prostate using 80-W and 120-W laser versus transurethral resection of the prostate for benign prost
2. Danilov VV, Osinkin KS, Danilov VV, Sevryukov F.A. Alpha1-blockers and detrusor hyperactivity in patients with prostate adenoma. Questions of urology and andrology. 2018.Vol. 6. No. 2. P. 49-53.
3. Ilchenko G.V., Ischenko O.Yu., Lynova E.N., Prishchep L.V. Assessment of organizational loyalty in medical institutions. International Journal of Medicine and Psychology. 2018. Volume 1. No. 4. S. 24-35.
4. Kamyshov S.V., Pulatov D.A., Yuldasheva N.Sh., Balenkov O.Yu. Study of the influence of immunotherapy methods on peroxidation processes in the accompanying treatment of cervical cancer. Eurasian Oncology Journal. 2015. No. 4 (7). S. 60-66.
5. Kulikova N.G., Kamurzoeva S.Sh. Medical and social characteristics of patients of working age with primary disability. Problems of social hygiene, health care and the history of medicine. 2014.Vol. 22. No. 2. P. 14-16.
6. Pulatov D.A., Ibragimov Zh.M., Kamyshov S.V. Comparative evaluation of the toxicity of treatment of patients with chemoresistant colorectal cancer. Oncology and radiology of Kazakhstan. 2017. No. 2 (44). S. 58-61.
7. Salalykina E.V., Papikyan O.A. Issues of optimizing the work of paramedical personnel in a central district hospital. International Journal of Medicine and Psychology. 2018. Volume 1. No. 2. S. 12-16.
8. Sevryukov F.A. The quality of life of patients after transurethral enucleation of large prostate adenomas. Andrology and genital surgery. 2012. T. 13. No. 3. P. 42-46.
9. Sevryukov F.A. Transurethral resection in saline. Urology. 2012. No. 2. P. 67-70.
10. Sevryukov F.A., Kamaev I.A., Malinina O.Yu., Mushroom M.N., Perevezentsev E.A. The social status of patients suffering from benign prostatic hyperplasia. Public health and healthcare. 2011. No 1. S. 53-56.
11. Sevryukov F.A., Malinina O.Yu. New organizational technologies for providing medical care to patients with benign prostatic hyperplasia. Social aspects of public health. 2012. V. 23. No. 1. S. 1-7.
12. Sevryukov F.A., Puchkin A.B., Krupin V.N., Chebykin A.V., Sorokin D.A., Karpukhin I.V., Malinina O.Yu., Zorin D.G. New Generation Transurethral Electrosurgery (TURIS) in the treatment of diseases of the lower urinary tract and prostate. Urology. 2007. No. 3. P. 28-35.
13. Sevryukov F.A., Serebryany S.A. A case of successful transurethral enucleation of prostate adenoma is very large. Andrology and genital surgery. 2012.V. 13. No. 3. S. 101-103.
14. Semenychev D.V., Sevryukov F.A., Sorokin D.A., Karpukhin I.V., Puchkin A.B., Kochkin A.D. Experience with the use of bipolar vapor resection of the prostate gland (TUVRB) in the treatment of BPH. Experimental and clinical urology. 2014. No. 2. P. 49-53.
15. Semenychev D.V., Sevryukov F.A., Sorokin D.A., Karpukhin I.V., Puchkin A.B., Kochkin A.D., Knutov A.V. Comparative evaluation of the effectiveness of various energy blocks in bipolar prostate surgery. Pacific Medical Journal. 2017. No. 1 (67). S. 88-90.
16. Sorokin D.A., Sevryukov F.A., Semenychev D.V., Karpukhin I.V., Puchkin A.B., Kochkin A.D., Knutov A.V. The results of the use of hyaluronic acid after transurethral endoscopic surgery for benign prostatic hyperplasia. Medical Bulletin of Bashkortostan. 2015.V. 10. No. 3. P. 19-24.
17. Urology. Russian Clinical Recommendations, ed. Yu. G. Alyaev, P.V. Glybochko, D. Yu. Pushkar. M.: GEOTAR-Media, 2016.496 s.
18. Khamurzoeva S.Sh., Kulikova N.G. Ways to reduce disability in people of working age. Problems of social hygiene, health care and the history of medicine. 2013. No. 6. S. 29-31.
19. Bachmann A, Tubaro A, Barber N, d’Ancona F, Muir G, Witzsch U et al. 180-W XPS GreenLight laser vaporisation versus transurethral resection of the prostate for the treatment of benign prostatic obstruction: 6-month safety and efficacy results of a European Multicentre Randomised Trial–the Goliath study Eur Urol. 2014. 65(5):931-942
20. da Silva R.D., Bidikov L., Michaels W. et al. Bipolar energy in the treatment of benign prostatic hyperplasia: a current systematic review of the literature. Can J Urol 2015;22 Suppl 1:30-44.
21. EAU guidelines on the treatment and follow-up of nonneurogenic male lower urinary tract symptoms including benign prostatic obstruction M. Oelke [et al.]. European Urology. 2013. Vol. 64, № 1. P. 118-140.
22. Geavlete B, Stanescu F, Iacoboaie C, Geavlete P. Bipolar plasma enucleation of the prostate vs open prostatectomy in large benign prostatic hyperplasia cases - A medium term, prospective, randomized comparison. BJU Int. 2013 May;111(5):793-803.
23. Lee Y.T., Ryu Y.W., Lee D.M. at al. Comparative Analysis of the Efficacy and Safety of Conventional Transurethral Resection of the Prostate, Transurethral Resection of the Prostate in Saline (TURIS), and TURIS-Plasma Vaporization for the Treatment of BPH: A Pilot Study. Korean J Urol. 2011. Nov; 52(11). Р. 763-8.
24. Nakagava, K. A new minimally invasive medical treatment for prostatic hyperplasia: its current situation and actual practice of the operation; TUEB. K. Nakagava. Urology View. 2007. Vol. 5. P. 95-97.
25. Reich O, Gratzke C, Bachmann A, Seitz M, Schlenker B, Hermanek P et al. Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10,654 patients. J Urol. 2008. 180(1):246-249.
26. Serretta V, Morgia G, Fondacaro L, Curto G, Lo bianco A, Pirritano D et al Open prostatectomy for benign prostatic enlargement in southern Europe in the late 1990s: a contemporary series of 1800 interventions. Urology. 2002. 60(4):623-627
27. Thangasamy IA, Chalasani V, Bachmann A, Woo HH. Photoselective vaporisation of the prostate using 80-W and 120-W laser versus transurethral resection of the prostate for benign prost
Additional Files
Published
2018-12-25
How to Cite
Perchatkin, V. A., & Kasimov, M. R. (2018). Comparative analysis of the efficiency of plasma transusretral methods of treatment of benign prostatic hyperplasia. Voprosy Ecologii, 8(4), 31–40. https://doi.org/10.25726/NM.2019.49.40.004
Issue
Section
Articles
